{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T04:11:44Z","timestamp":1748751104243,"version":"3.41.0"},"reference-count":76,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"JC STEM Lab of Digital Oncology Care Enhancement"},{"name":"Hong Kong Jockey Club Charities Trust"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Prostate cancer (PCa) significantly impacts patients\u2019 sexual functioning and quality of life. Patient-reported outcome measures (PROMs) are essential for accurately assessing these issues, yet a comprehensive evaluation of their psychometric properties in PCa patients is lacking.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>This systematic review aimed to provide a comprehensive evaluation of all generic and specific PROMs used to assess sexual functioning in PCa patients and make recommendations the application of PROMs in this patient group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Six electronic databases were searched from up to May 5, 2024. Studies reporting the development and\/or validation of PROMs for PCa patients or generic instruments administered to this population were included. The COSMIN risk of bias checklist was adopted to assess the methodological quality and psychometric properties of included PROMs. Psychometric properties of the PROM in each included study were rated against the criteria for good measurement properties based on the COSMIN guideline.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>The main outcome was to identify the appropriate PROM that can be adopted and used for assessing sexual functioning in PCa patients in clinical setting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 10 PROMs were identified across 32 studies, primarily focusing on localized PCa patients after radical prostatectomy. The Expanded Prostate Cancer Index Composite (EPIC-26) was the most frequently evaluated and widely used PROM in clinical practice. EPIC-26 (Spanish, Italian, Chinese versions) and UCLA Prostate Cancer Index (UCLA-PCI) demonstrated better psychometric properties compared to other scales. However, no PROM met\u00a0all COSMIN standards.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>In a clinical setting, it is crucial to utilize well-validated PROMs with good psychometric properties to effectively identify patients with PCa experiencing sexual difficulties who may require additional support.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths and Limitations<\/jats:title>\n                  <jats:p>We applied strict inclusion criteria related to study design and study population, ensuring the assumption of transitivity and the consistency of the analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Although EPIC-26 is a shortened version with strong psychometric properties, it may still be too lengthy for patients with significant health issues. Furthermore, the included PROMs do not address issues related to partner relationships, or the psychological impact of sexual dysfunction in sufficient detail. Future research should aim to develop and validate new PROMs that fill these gaps. These tools should be both psychometrically robust and practical for routine use, enabling real-time monitoring and improved care delivery.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jsxmed\/qdaf018","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T04:56:01Z","timestamp":1740027361000},"page":"605-624","source":"Crossref","is-referenced-by-count":0,"title":["Patient-reported outcome measures (PROMs) used to assess sexual functioning in prostate cancer patients: a systematic review of psychometric properties"],"prefix":"10.1093","volume":"22","author":[{"given":"Hammoda","family":"Abu-Odah","sequence":"first","affiliation":[{"name":"School of Nursing, The Hong Kong Polytechnic University , Hung Hom, Hong Kong SAR, 999077 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ka-Yan","family":"Ho","sequence":"additional","affiliation":[{"name":"School of Nursing, The Hong Kong Polytechnic University , Hung Hom, Hong Kong SAR, 999077 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Fai","family":"Ng","sequence":"additional","affiliation":[{"name":"SH Ho Urology Center, Department of Surgery, The Chinese University of Hong Kong , Hong Kong SAR, 999077 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Nursing, The First Affiliated Hospital of Zhejiang University School of Medicine , Hangzhou ,","place":["China"]},{"name":"Department of Nursing, School of Medicine, Zhejiang University , Hangzhou 310058 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine-Ka-Wai","family":"Lam","sequence":"additional","affiliation":[{"name":"School of Nursing, The Hong Kong Polytechnic University , Hung Hom, Hong Kong SAR, 999077 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janelle","family":"Yorke","sequence":"additional","affiliation":[{"name":"School of Nursing, The Hong Kong Polytechnic University , Hung Hom, Hong Kong SAR, 999077 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"1","key":"2025053111220022600_ref1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2025053111220022600_ref2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.eururo.2023.06.012","article-title":"Clinical characterization of patients diagnosed with prostate cancer and undergoing conservative management: a PIONEER analysis based on big data","volume":"85","author":"Gandaglia","year":"2024","journal-title":"Eur Urol"},{"issue":"10305","key":"2025053111220022600_ref3","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","article-title":"Prostate cancer","volume":"398","author":"Sandhu","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"2025053111220022600_ref4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.esxm.2018.06.002","article-title":"Scandinavian prostate cancer patients\u2019 sexual problems and satisfaction with their sex life following anti-cancer treatment","volume":"6","author":"Martin Hald","year":"2018","journal-title":"Sex Med"},{"issue":"1","key":"2025053111220022600_ref5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/smrj.17","article-title":"Sexual function in elderly men receiving androgen deprivation therapy (ADT)","volume":"2","author":"Fode","year":"2014","journal-title":"Sex Med Rev"},{"issue":"2","key":"2025053111220022600_ref6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5534\/wjmh.2012.30.2.99","article-title":"Prostate cancer and sexual function","volume":"30","author":"Hyun","year":"2012","journal-title":"World J Mens Health"},{"issue":"1","key":"2025053111220022600_ref7","first-page":"218","article-title":"Sexual dysfunction and quality of life in prostate cancer","volume":"43","author":"Teixeira","year":"2020","journal-title":"Revista ROL de Enfermer\u00eda"},{"issue":"4","key":"2025053111220022600_ref8","doi-asserted-by":"publisher","first-page":"163.e7","DOI":"10.1016\/j.urolonc.2014.11.018","article-title":"Natural history of surgically treated high-risk prostate cancer","volume":"33","author":"Briganti","year":"2015","journal-title":"Urol Oncol"},{"issue":"9","key":"2025053111220022600_ref9","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1002\/1529-0131(199909)42:9&lt;1797::AID-ANR2&gt;3.0.CO;2-Q","article-title":"Listening to the patient: a practical guide to self-report questionnaires in clinical care","volume":"42","author":"Wolfe","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"24","key":"2025053111220022600_ref10","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1093\/jnci\/djr493","article-title":"Use of patient-reported outcomes to improve the predictive accuracy of clinician-reported adverse events","volume":"103","author":"Basch","year":"2011","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"6","key":"2025053111220022600_ref11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.jpainsymman.2009.05.025","article-title":"Assessing the symptoms of cancer using patient-reported outcomes (ASCPRO): searching for standards","volume":"39","author":"Cleeland","year":"2010","journal-title":"J Pain Symptom Manag"},{"issue":"6","key":"2025053111220022600_ref12","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/mds.20383","article-title":"Identification of motor and nonmotor wearing-off in Parkinson\u2019s disease: comparison of a patient questionnaire versus a clinician assessment","volume":"20","author":"Stacy","year":"2005","journal-title":"Mov Disord"},{"volume-title":"Silver","year":"2009","author":"U.S. Department of Health and Human Services, Food and Drug Administration","key":"2025053111220022600_ref13"},{"volume-title":"Guidance for Industry. Patient-Reported Outcome Measures: Use in Medicinal Product Development to Support Labeling Claims","year":"2009","author":"","key":"2025053111220022600_ref14"},{"issue":"1","key":"2025053111220022600_ref15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/009262300278623","article-title":"The Arizona sexual experience scale (ASEX): reliability and validity","volume":"26","author":"McGahuey","year":"2000","journal-title":"J Sex Marital Ther"},{"issue":"2","key":"2025053111220022600_ref16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"issue":"6","key":"2025053111220022600_ref17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41585-023-00778-3","article-title":"Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer","volume":"20","author":"Dickstein","year":"2023","journal-title":"Nat Rev Urol"},{"issue":"5","key":"2025053111220022600_ref18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/lgbt.2018.0245","article-title":"A pilot study assessing aspects of sexual function predicted to Be important after treatment for prostate cancer in gay men: an underserved domain highlighted","volume":"7","author":"Amarasekera","year":"2020","journal-title":"LGBT Health"},{"issue":"6","key":"2025053111220022600_ref19","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1046\/j.1464-410X.1998.00868.x","article-title":"The evaluation of sexual function in men presenting with symptomatic benign prostatic hyperplasia","volume":"82","author":"Namasivayam","year":"1998","journal-title":"Br J Urol"},{"issue":"7","key":"2025053111220022600_ref20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","article-title":"The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes","volume":"63","author":"Mokkink","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"2025053111220022600_ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"5","key":"2025053111220022600_ref22","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s11136-018-1829-0","article-title":"COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study","volume":"27","author":"Terwee","year":"2018","journal-title":"Qual Life Res"},{"issue":"4","key":"2025053111220022600_ref23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s11136-011-9960-1","article-title":"Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist","volume":"21","author":"Terwee","year":"2012","journal-title":"Qual Life Res"},{"issue":"9","key":"2025053111220022600_ref24","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1164\/rccm.201702-0372OC","article-title":"Core outcome measures for clinical research in acute respiratory failure survivors. An international modified Delphi consensus study","volume":"196","author":"Needham","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2025053111220022600_ref25","first-page":"6","article-title":"COSMIN methodology for systematic reviews of patient-reported outcome measures (PROMs)","volume":"78","author":"Mokkink","year":"2018","journal-title":"User manual"},{"issue":"1","key":"2025053111220022600_ref26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13643-019-1119-0","article-title":"Performance properties of health-related measurement instruments in whiplash: systematic review protocol","volume":"8","author":"Abedi","year":"2019","journal-title":"Syst Rev"},{"issue":"5","key":"2025053111220022600_ref27","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s11136-018-1798-3","article-title":"COSMIN guideline for systematic reviews of patient-reported outcome measures","volume":"27","author":"Prinsen","year":"2018","journal-title":"Qual Life Res"},{"issue":"12","key":"2025053111220022600_ref28","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1007\/s00345-023-04691-7","article-title":"Psychometric validation of the Spanish version of the expanded prostate cancer index composite-26","volume":"41","author":"Zamora","year":"2023","journal-title":"World J Urol"},{"issue":"1","key":"2025053111220022600_ref29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12885-023-10732-6","article-title":"Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer","volume":"23","author":"Bulamu","year":"2023","journal-title":"BMC Cancer"},{"issue":"4","key":"2025053111220022600_ref30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/ajco.13894","article-title":"Development and pilot-testing of the expanded prostate index composite\u2014Filipino version (EPIC-F)","volume":"19","author":"Bacorro","year":"2023","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1","key":"2025053111220022600_ref31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00345-019-02949-7","article-title":"Psychometric validation of the German version of the EPIC-26 questionnaire for patients with localized and locally advanced prostate cancer","volume":"39","author":"Sibert","year":"2021","journal-title":"World J Urol"},{"issue":"4","key":"2025053111220022600_ref32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.5213\/inj.2040316.158","article-title":"Translation and linguistic validation of Korean version of the expanded prostate cancer index composite for clinical practice for patients with prostate cancer","volume":"25","author":"Hwang","year":"2021","journal-title":"Int Neurourol J"},{"issue":"1","key":"2025053111220022600_ref33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12894-020-00734-y","article-title":"Portuguese version of the expanded prostate cancer index composite for clinical practice (EPIC-CP): psychometric validation and prospective application for early functional outcomes at a single institution","volume":"20","author":"Louren\u00e7o","year":"2020","journal-title":"BMC Urol"},{"issue":"4","key":"2025053111220022600_ref34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5489\/cuaj.5997","article-title":"Evaluating the measurement properties of the 26-item expanded prostate cancer index composite (EPIC-26) with a multicenter cohort","volume":"14","author":"Crump","year":"2020","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"2025053111220022600_ref35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12955-019-1214-x","article-title":"Validation of the Italian version of the abbreviated expanded prostate cancer index composite (EPIC-26) in men with prostate cancer","volume":"17","author":"Marzorati","year":"2019","journal-title":"Health Qual Life Outcomes"},{"key":"2025053111220022600_ref36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.urology.2019.02.004","article-title":"Expanded prostate cancer index Composite-26 (EPIC-26) online: validation of an internet-based instrument for assessment of health-related quality of life after treatment for localized prostate cancer","volume":"127","author":"Einstein","year":"2019","journal-title":"Urology"},{"issue":"3","key":"2025053111220022600_ref37","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s11136-018-2034-x","article-title":"A pilot evaluation of the expanded prostate cancer index composite for clinical practice (EPIC-CP) tool in Ontario","volume":"28","author":"Brundage","year":"2019","journal-title":"Qual Life Res"},{"issue":"23","key":"2025053111220022600_ref38","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1200\/JCO.18.01782","article-title":"Validity of the patient-reported outcome measurement information system (PROMIS) sexual interest and satisfaction measures in men following radical prostatectomy","volume":"37","author":"Agochukwu","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"2025053111220022600_ref39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12955-018-0859-1","article-title":"The German version of the expanded prostate cancer index composite (EPIC): translation, validation and minimal important difference estimation","volume":"16","author":"Umbehr","year":"2018","journal-title":"Health Qual Life Outcomes"},{"issue":"12","key":"2025053111220022600_ref40","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.jsxm.2018.09.015","article-title":"Psychometric evaluation of PROMIS sexual function and satisfaction measures in a longitudinal population-based cohort of men with localized prostate cancer","volume":"15","author":"Reeve","year":"2018","journal-title":"J Sex Med"},{"issue":"Suppl 1","key":"2025053111220022600_ref41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/ajco.12855","article-title":"Cultural adaptation and validation of the Chinese version of the expanded prostate cancer index composite","volume":"14","author":"Lee","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1","key":"2025053111220022600_ref42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12955-017-0670-4","article-title":"International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer","volume":"15","author":"Van Leeuwen","year":"2017","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"2025053111220022600_ref43","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jpainsymman.2017.02.010","article-title":"Psychometric assessment of the Chinese version of the abbreviated expanded prostate cancer index composite (EPIC-26) and the clinical practice version (EPIC-CP) in Chinese men with prostate cancer","volume":"53","author":"Lam","year":"2017","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"2025053111220022600_ref44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12894-017-0302-7","article-title":"Psychometric properties of the expanded prostate cancer index composite\u201426 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations","volume":"17","author":"Axcrona","year":"2017","journal-title":"BMC Urol"},{"issue":"1","key":"2025053111220022600_ref45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-016-0571-y","article-title":"Cross-cultural adaptation and validation of the French version of the expanded prostate cancer index composite questionnaire for health-related quality of life in prostate cancer patients","volume":"14","author":"Anota","year":"2016","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"2025053111220022600_ref46","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s11136-014-0701-0","article-title":"Adaptation and validation of the Spanish version of the patient-oriented prostate utility scale (PORPUS)","volume":"23","author":"\u00c1vila","year":"2014","journal-title":"Qual Life Res"},{"issue":"6","key":"2025053111220022600_ref47","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.urology.2009.04.070","article-title":"Responsiveness of the University of California-Los Angeles Prostate Cancer Index","volume":"75","author":"Bergman","year":"2010","journal-title":"Urology"},{"issue":"3","key":"2025053111220022600_ref48","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.juro.2011.04.085","article-title":"Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer","volume":"186","author":"Chang","year":"2011","journal-title":"J Urol"},{"issue":"9","key":"2025053111220022600_ref49","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s11136-016-1254-1","article-title":"The internal and external responsiveness of functional assessment of cancer therapy-prostate (FACT-P) and short Form-12 health survey version 2 (SF-12 v2) in patients with prostate cancer","volume":"25","author":"Choi","year":"2016","journal-title":"Qual Life Res"},{"issue":"4","key":"2025053111220022600_ref50","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3109\/21681805.2016.1163617","article-title":"Psychometric testing of the Norwegian version of the expanded prostate cancer index composite 26-item version (EPIC-26)","volume":"50","author":"Foss\u00e5","year":"2016","journal-title":"Scand J Urol"},{"issue":"2","key":"2025053111220022600_ref51","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.urology.2005.02.027","article-title":"Quality of life after radical treatment of prostate cancer: validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index","volume":"66","author":"Gacci","year":"2005","journal-title":"Urology"},{"issue":"5","key":"2025053111220022600_ref52","doi-asserted-by":"publisher","first-page":"0306","DOI":"10.1007\/s101470200045","article-title":"Development of Japanese version of the UCLA prostate cancer index: a pilot validation study","volume":"7","author":"Kakehi","year":"2002","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"2025053111220022600_ref53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.urology.2004.08.054","article-title":"Reliability of remembered international index of erectile function domain scores in men with localized prostate cancer","volume":"65","author":"Karakiewicz","year":"2005","journal-title":"Urology"},{"issue":"2","key":"2025053111220022600_ref54","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0090-4295(02)02245-8","article-title":"Cross-cultural validation of the UCLA prostate cancer index","volume":"61","author":"Karakiewicz","year":"2003","journal-title":"Urology"},{"issue":"6","key":"2025053111220022600_ref55","doi-asserted-by":"publisher","first-page":"e0157460","DOI":"10.1371\/journal.pone.0157460","article-title":"Rasch analysis of the premature ejaculation diagnostic tool (PEDT) and the international index of erectile function (IIEF) in an Iranian sample of prostate cancer patients","volume":"11","author":"Lin","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"2025053111220022600_ref56","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1097\/00005650-199807000-00007","article-title":"The UCLA prostate cancer index: development, reliability, and validity of a health-related quality of life measure","volume":"36","author":"Litwin","year":"1998","journal-title":"Med Care"},{"issue":"6","key":"2025053111220022600_ref57","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","article-title":"Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer","volume":"56","author":"Wei","year":"2000","journal-title":"Urology"},{"issue":"4","key":"2025053111220022600_ref58","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1023\/A:1023402706666","article-title":"Measuring disease specific quality of life in localized prostate cancer: the Dutch experience","volume":"12","author":"Korfage","year":"2003","journal-title":"Qual Life Res"},{"issue":"1","key":"2025053111220022600_ref59","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s00345-005-0023-5","article-title":"Validation of the German prostate-specific module","volume":"24","author":"Bestmann","year":"2006","journal-title":"World J Urol"},{"article-title":"Development of Japanese version of the UCLA prostate cancer index: a pilot validation study","volume-title":"Int J Clin Oncol","author":"","key":"2025053111220022600_ref60"},{"issue":"1","key":"2025053111220022600_ref61","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4103\/aja.aja_75_18","article-title":"Time trend and characteristics of prostate cancer diagnosed in Hong Kong (China) in the past two decades","volume":"21","author":"Wong","year":"2019","journal-title":"Asian J Androl"},{"key":"2025053111220022600_ref62","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511996214","volume-title":"Measurement in Medicine: A Practical Guide. of Practical Guides to Biostatistics and Epidemiology","author":"De Vet","year":"2011"},{"issue":"1","key":"2025053111220022600_ref63","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/bmb\/ldw050","article-title":"Cancer burden with ageing population in urban regions in China: projection on cancer registry data from World Health Organization","volume":"121","author":"Tsoi","year":"2016","journal-title":"Br Med Bull"},{"issue":"2","key":"2025053111220022600_ref64","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamasurg.2021.6215","article-title":"Patient- and surgeon-level variation in patient-reported sexual function outcomes following radical prostatectomy over 2 years: results from a statewide surgical improvement collaborative","volume":"157","author":"Agochukwu-Mmonu","year":"2022","journal-title":"JAMA Surgery"},{"issue":"6","key":"2025053111220022600_ref65","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"issue":"2","key":"2025053111220022600_ref66","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0090-4295(99)00099-0","article-title":"Diagnostic evaluation of the erectile function domain of the international index of erectile function","volume":"54","author":"Cappelleri","year":"1999","journal-title":"Urology"},{"issue":"2","key":"2025053111220022600_ref67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.euo.2021.10.004","article-title":"Standardising the assessment of patient-reported outcome measures in localised prostate cancer","volume":"5","author":"Ratti","year":"2022","journal-title":"A Systematic Review European Urology Oncology"},{"key":"2025053111220022600_ref68","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-020-00493-w","article-title":"The Use of Patient-Reported Outcome Measures in Rare Diseases and Implications for Health Technology Assessment","volume-title":"Patient","author":""},{"issue":"3","key":"2025053111220022600_ref69","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.eururo.2014.08.075","article-title":"Defining a standard set of patient-centered outcomes for men with localized prostate cancer","volume":"67","author":"Martin","year":"2015","journal-title":"Eur Urol"},{"issue":"5B","key":"2025053111220022600_ref70","doi-asserted-by":"publisher","first-page":"E64","DOI":"10.1111\/bju.13854","article-title":"A core outcome set for localised prostate cancer effectiveness trials","volume":"120","author":"MacLennan","year":"2017","journal-title":"BJU Int"},{"issue":"5","key":"2025053111220022600_ref71","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/bju.14368","article-title":"Evaluating patient-reported outcome measures (PROMs) for bladder cancer: a systematic review using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist","volume":"122","author":"Mason","year":"2018","journal-title":"BJU Int"},{"issue":"s1","key":"2025053111220022600_ref72","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1111\/j.1524-4733.2004.7s106.x","article-title":"Application of Rasch analysis in the development and application of quality of life instruments","volume":"7","author":"Tennant","year":"2004","journal-title":"Value Health"},{"issue":"5","key":"2025053111220022600_ref73","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s11136-017-1765-4","article-title":"COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures","volume":"27","author":"Mokkink","year":"2018","journal-title":"Qual Life Res"},{"issue":"2","key":"2025053111220022600_ref74","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","article-title":"Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation","volume":"8","author":"Wild","year":"2005","journal-title":"Value Health"},{"issue":"2","key":"2025053111220022600_ref75","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0895-4356(97)00269-2","article-title":"Responsiveness to change in health-related quality of life in a randomized clinical trial: a comparison of the prostate cancer specific quality of life instrument (PROSQOLI) with analogous scales from the EORTC QLQ-C30 and a trial specific module. European Organization for Research and Treatment of Cancer","volume":"51","author":"Stockler","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2025053111220022600_ref76","doi-asserted-by":"publisher","DOI":"10.1201\/9780429258589","volume-title":"Practical Statistics for Medical Research","author":"Altman","year":"1990"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/4\/605\/62005594\/qdaf018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/4\/605\/62005594\/qdaf018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T15:22:09Z","timestamp":1748704929000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/22\/4\/605\/8025944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":76,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2,20]]},"published-print":{"date-parts":[[2025,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/jsxmed\/qdaf018","relation":{},"ISSN":["1743-6095","1743-6109"],"issn-type":[{"type":"print","value":"1743-6095"},{"type":"electronic","value":"1743-6109"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,2,20]]}}}